Lumida
/PLX
⌘K
Protalix Biotherapeutics Inc

Protalix Biotherapeutics Inc

PLX
$2.41USD+1.26%+0.03 today

MARKET CAP

194.2M

P/E (TTM)

9.7x

FWD P/E

DAY RANGE

$2 – $2

52W RANGE

$2
$3

AI Summary

Stalk
Sell NowHigh

PLX is in a clear downtrend, trading below all major EMAs with sequential lower highs and lower lows. Despite oversold RSI, there is no visible exhaustion or sustained repair, and declining volume remains dominant. The medium-term bearish bias is reinforced by price action, supporting a Sell Now approach into any bounce or EMA retest.

  • Q1 EPS beat: reported $0.22 vs -$0.0101 estimate, showing strong execution.
  • 2026 revenue guidance maintained at $78M–$83M, including $25M Chiesi milestone.
  • No Q1 revenue disclosed, fueling quarterly revenue volatility concerns.
Full analysis →
Sales, Adj.
Gross Profit, Adj.
EBITDA, Adj.
EBIT
Net Income